pharmacopeia

Vanadium

US-FDASourced from openFDA
GET
/api/v1/drug/vanadium

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
47 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Nausea715%
  2. 2Fatigue613%
  3. 3Insomnia613%
  4. 4Asthenia511%
  5. 5Drug Ineffective511%
  6. 6Palpitations511%
  7. 7Vomiting511%
  8. 8Back Pain48.5%
  9. 9Feeling Abnormal48.5%
  10. 10Headache48.5%
  11. 11Pain48.5%
  12. 12Tinnitus48.5%
  13. 13Chest Pain36.4%
  14. 14Dizziness36.4%
  15. 15Neuropathy Peripheral36.4%

Literature

View JSON

Recent PubMed references pinned to Vanadium as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 14 ClinicalTrials.gov registrations naming Vanadium as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Note. Data for vanadium is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients